About this Journal Submit a Manuscript Table of Contents 
ISRN Oncology
Volume 2012 (2012), Article ID 137289, 21 pages
doi:10.5402/2012/137289
Review Article

Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy

Giuseppina Barrera

Department of Medicine and Experimental Oncology, University of Turin, Corso Raffaello 30, 10125 Torino, Italy

Received 24 July 2012; Accepted 28 August 2012

Academic Editors: P. Balaram, B. Fang, N. Fujimoto, and O. Hansen

Copyright © 2012 Giuseppina Barrera. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Hybertson, B. Gao, S. K. Bose, and J. M. McCord, “Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation,” Molecular Aspects of Medicine, vol. 32, pp. 234–246, 2011.
  2. B. Lipinski, “Hydroxyl radical and its scavengers in health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 809696, 9 pages, 2011. View at Publisher · View at Google Scholar
  3. M. L. Riess, A. K. S. Camara, L. G. Kevin, J. An, and D. F. Stowe, “Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17°C ischemia in intact hearts,” Cardiovascular Research, vol. 61, no. 3, pp. 580–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Lü, P. H. Lin, Q. Yao, and C. Chen, “Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 840–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. A. Dix and J. Aikens, “Mechanisms and biological relevance of lipid peroxidation initiation,” Chemical Research in Toxicology, vol. 6, no. 1, pp. 2–18, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Y. Cheng and Y. Z. Li, “What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update,” Chemical Reviews, vol. 107, no. 3, pp. 748–766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Weisiger and I. Fridovich, “Superoxide dismutase. Organelle specificity,” Journal of Biological Chemistry, vol. 248, no. 10, pp. 3582–3592, 1973. View at Scopus
  8. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Scopus
  9. M. K. Misra, M. Sarwat, P. Bhakuni, R. Tuteja, and N. Tuteja, “Oxidative stress and ischemic myocardial syndromes,” Medical Science Monitor, vol. 15, no. 10, pp. RA209–RA219, 2009. View at Scopus
  10. B. Halliwell, S. Chirico, M. A. Crawford, K. S. Bjerve, and K. F. Gey, “Lipid peroxidation: its mechanism, measurement, and significance,” American Journal of Clinical Nutrition, vol. 57, no. 5, pp. 715S–724S, 1993. View at Scopus
  11. H. W. Gardner, “Oxygen radical chemistry of polyunsaturated fatty acids,” Free Radical Biology and Medicine, vol. 7, no. 1, pp. 65–86, 1989. View at Scopus
  12. P. Spiteller, W. Kern, J. Reiner, and G. Spiteller, “Aldehydic lipid peroxidation products derived from linoleic acid,” Biochimica et Biophysica Acta, vol. 1531, no. 3, pp. 188–208, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Barrera, S. Pizzimenti, and M. U. Dianzani, “Lipid peroxidation: control of cell proliferation, cell differentiation and cell death,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Pizzimenti, C. Toaldo, P. Pettazzoni, M. U. Dianzani, and G. Barrera, “The “Two-Faced” effects of reactive oxygen species and the lipid peroxidation product 4-Hydroxynonenal in the hallmarks of cancer,” Cancers, vol. 2, no. 2, pp. 338–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,” Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Uchida, “4-Hydroxy-2-nonenal: a product and mediator of oxidative stress,” Progress in Lipid Research, vol. 42, no. 4, pp. 318–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Uchida, L. I. Szweda, H. Z. Chae, and E. R. Stadtman, “Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8742–8746, 1993. View at Scopus
  18. L. M. Sayre, W. Sha, G. Xu et al., “Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal,” Chemical Research in Toxicology, vol. 9, no. 7, pp. 1194–1201, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Xu, Y. Liu, and L. M. Sayre, “Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross- linking of proteins by (E)-4-hydroxy-2-nonenal,” Journal of Organic Chemistry, vol. 64, no. 16, pp. 5732–5745, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. J. Forman, J. M. Fukuto, T. Miller, H. Zhang, A. Rinna, and S. Levy, “The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal,” Archives of Biochemistry and Biophysics, vol. 477, no. 2, pp. 183–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. T. P. Szatrowski and C. F. Nathan, “Production of large amounts of hydrogen peroxide by human tumor cells,” Cancer Research, vol. 51, no. 3, pp. 794–798, 1991. View at Scopus
  22. S. Kawanishi, Y. Hiraku, S. Pinlaor, and N. Ma, “Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis,” Biological Chemistry, vol. 387, no. 4, pp. 365–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhou, E. O. Hileman, W. Plunkett, M. J. Keating, and P. Huang, “Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents,” Blood, vol. 101, no. 10, pp. 4098–4104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. S. Kamiguti, L. Serrander, K. Lin et al., “Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia,” Journal of Immunology, vol. 175, no. 12, pp. 8424–8430, 2005. View at Scopus
  25. E. Chow, C. Thirlwell, F. Macrae, and L. Lipton, “Colorectal cancer and inherited mutations in base-excision repair,” Lancet Oncology, vol. 5, no. 10, pp. 600–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Young, T. Crotty, R. O'Connell, J. O'Sullivan, and A. J. Curran, “Levels of oxidative damage and lipid peroxidation in thyroid neoplasia,” Head and Neck, vol. 32, no. 6, pp. 750–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. B. P. Patel, U. M. Rawal, T. K. Dave et al., “Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma,” Integrative Cancer Therapies, vol. 6, no. 4, pp. 365–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Tsao, M. C. Yin, and W. H. Liu, “Oxidant stress and B vitamins status in patients with non-small cell lung cancer,” Nutrition and Cancer, vol. 59, no. 1, pp. 8–13, 2007. View at Scopus
  29. B. Kumar, S. Koul, L. Khandrika, R. B. Meacham, and H. K. Koul, “Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype,” Cancer Research, vol. 68, no. 6, pp. 1777–1785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Boonstra and J. A. Post, “Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells,” Gene, vol. 337, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Q. Schafer and G. R. Buettner, “Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple,” Free Radical Biology and Medicine, vol. 30, no. 11, pp. 1191–1212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Toyokuni, “Persistent oxidative stress in cancer,” FEBS Letters, vol. 358, no. 1, pp. 1–3, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. T. D. Oberley, “Antioxidant enzyme levels in cancer,” Histology and Histopathology, vol. 12, no. 2, pp. 525–535, 1997. View at Scopus
  34. Y. Hu, D. G. Rosen, Y. Zhou et al., “Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress,” Journal of Biological Chemistry, vol. 280, no. 47, pp. 39485–39492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Saydam, A. Kirb, O. Demir et al., “Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues,” Cancer Letters, vol. 119, no. 1, pp. 13–19, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Murawaki, H. Tsuchiya, T. Kanbe et al., “Aberrant expression of selenoproteins in the progression of colorectal cancer,” Cancer Letters, vol. 259, no. 2, pp. 218–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Irani, Y. Xia, J. L. Zweier et al., “Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts,” Science, vol. 275, no. 5306, pp. 1649–1652, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. M. S. Rodrigues, M. M. Reddy, and M. Sattler, “Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications,” Antioxidants and Redox Signaling, vol. 10, no. 10, pp. 1813–1848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Brandon, P. Baldi, and D. C. Wallace, “Mitochondrial mutations in cancer,” Oncogene, vol. 25, no. 34, pp. 4647–4662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. S. Bae, J. Y. Sung, O. S. Kim et al., “Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase,” Journal of Biological Chemistry, vol. 275, no. 14, pp. 10527–10531, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Y. Liou and P. Storz, “Reactive oxygen species in cancer,” Free Radical Research, vol. 44, no. 5, pp. 479–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Balkwill, “Tumour necrosis factor and cancer,” Nature Reviews Cancer, vol. 9, no. 5, pp. 361–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Berasain, J. Castillo, M. J. Perugorria, M. U. Latasa, J. Prieto, and M. A. Avila, “Inflammation and liver cancer: new molecular links,” Annals of the New York Academy of Sciences, vol. 1155, pp. 206–221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Hammer, M. Ferro, H. M. Tillian et al., “Effect of oxidative stress by iron on 4-hydroxynonenal formation and proliferative activity in hepatomas of different degrees of differentiation,” Free Radical Biology and Medicine, vol. 23, no. 1, pp. 26–33, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. R. A. Canuto, G. Muzio, M. Maggiora, M. E. Biocca, and M. U. Dianzani, “Glutathione-S-transferase, alcohol dehydrogenase and aldehyde reductase activities during diethylnitrosamine-carcinogenesis in rat liver,” Cancer Letters, vol. 68, no. 2-3, pp. 177–183, 1993. View at Scopus
  46. R. B. Tjalkens, L. W. Cook, and D. R. Petersen, “Formation and export of the glutathione conjugate of 4-hydroxy-2,3-E- nonenal (4-HNE) in hepatoma cells,” Archives of Biochemistry and Biophysics, vol. 361, no. 1, pp. 113–119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. T. D. Oberley, S. Toyokuni, and L. I. Szweda, “Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers,” Free Radical Biology and Medicine, vol. 27, no. 5-6, pp. 695–703, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Zanetti, G. Poli, B. Vizio, B. Zingaro, E. Chiarpotto, and F. Biasi, “4-Hydroxynonenal and transforming growth factor-β1 expression in colon cancer,” Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 273–280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Skrzydlewska, A. Stankiewicz, M. Sulkowska, S. Sulkowski, and I. Kasacka, “Antioxidant status and lipid peroxidation in colorectal cancer,” Journal of Toxicology and Environmental Health A, vol. 64, no. 3, pp. 213–222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Young, T. Crotty, R. O'Connell, J. O'Sullivan, and A. J. Curran, “Levels of oxidative damage and lipid peroxidation in thyroid neoplasia,” Head and Neck, vol. 32, no. 6, pp. 750–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Juric-Sekhar, K. Zarkovic, G. Waeg, A. Cipak, and N. Zarkovic, “Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain,” Tumori, vol. 95, no. 6, pp. 762–768, 2009. View at Scopus
  52. P. Karihtala, S. Kauppila, U. Puistola, and A. Jukkola-Vuorinen, “Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis,” Histopathology, vol. 58, no. 6, pp. 854–862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Dwivedi, A. Sharma, B. Patrick, R. Sharma, and Y. C. Awasthi, “Role of 4-hydroxynonenal and its metabolites in signaling,” Redox Report, vol. 12, no. 1-2, pp. 4–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Storz, “Reactive oxygen species in tumor progression,” Frontiers in Bioscience, vol. 10, no. 2, pp. 1881–1896, 2005. View at Scopus
  55. M. Parola, G. Bellomo, G. Robino, G. Barrera, and M. U. Dianzani, “4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications,” Antioxidants & Redox Signaling, vol. 1, no. 3, pp. 255–284, 1999.
  56. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. J. L. Martindale and N. J. Holbrook, “Cellular response to oxidative stress: signaling for suicide and survival,” Journal of Cellular Physiology, vol. 192, no. 1, pp. 1–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Benhar, D. Engelberg, and A. Levitzki, “ROS, stress-activated kinases and stress signaling in cancer,” EMBO Reports, vol. 3, no. 5, pp. 420–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. S. S. Leonard, G. K. Harris, and X. Shi, “Metal-induced oxidative stress and signal transduction,” Free Radical Biology and Medicine, vol. 37, no. 12, pp. 1921–1942, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Boonstra and J. A. Post, “Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells,” Gene, vol. 337, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. R. C. Rancourt, P. C. Keng, C. E. Helt, and M. A. O'Reilly, “The role of P21CIP1/WAF1 in growth of epithelial cells exposed to hyperoxia,” American Journal of Physiology, vol. 280, no. 4, pp. L617–L626, 2001. View at Scopus
  62. J. S. Shenberger and P. S. Dixon, “Oxygen induces S-phase growth arrest and increases p53 and p21WAF1/CIP1 expression in human bronchial smooth-muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 21, no. 3, pp. 395–402, 1999. View at Scopus
  63. C. E. Helt, R. C. Rancourt, R. J. Staversky, and M. A. O'Reilly, “p53-dependent induction of p21Cip1/WAF1/Sdi1 protects against oxygen-induced toxicity,” Toxicological Sciences, vol. 63, no. 2, pp. 214–222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Martìnez Muñoz, L. A. van Meeteren, J. A. Post, A. J. Verkleij, C. T. Verrips, and J. Boonstra, “Hydrogen peroxide inhibits cell cycle progression by inhibition of the spreading of mitotic CHO cells,” Free Radical Biology and Medicine, vol. 33, no. 8, pp. 1061–1072, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Thorn, R. Gniadecki, A. B. Petersen, J. Vicanova, and H. C. Wulf, “Differences in activation of G2/M checkpoint in keratinocytes after genotoxic stress induced by hydrogen peroxide and ultraviolet a radiation,” Free Radical Research, vol. 35, no. 4, pp. 405–416, 2001. View at Scopus
  66. Y. W. Chung, D. W. Jeong, J. Yun Won, E. J. Choi, Y. Hyun Choi, and I. Young Kim, “H2O2-induced AP-1 activation and its effect on P21CIP1/WAF1-mediated G2/M arrest in a p53-deficient human lung cancer cell,” Biochemical and Biophysical Research Communications, vol. 293, no. 4, pp. 1248–1253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Zhang, Y. Z. Wang, E. Kagan, and J. C. Bonner, “Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22479–22486, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Cadenas, “Mitochondrial free radical production and cell signaling,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 17–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. H. U. Simon, A. Haj-Yehia, and F. Levi-Schaffer, “Role of reactive oxygen species (ROS) in apoptosis induction,” Apoptosis, vol. 5, no. 5, pp. 415–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. M. Chung, Y. S. Bae, and S. Y. Lee, “Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis,” Free Radical Biology and Medicine, vol. 34, no. 4, pp. 434–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Caron, M. Auclair, A. Vissian, C. Vigouroux, and J. Capeau, “Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues,” Antiviral Therapy, vol. 13, no. 1, pp. 27–38, 2008. View at Scopus
  72. K. Ksiazek, J. F. Passos, S. Olijslagers, and T. von Zglinicki, “Mitochondrial dysfunction is a possible cause of accelerated senescence of mesothelial cells exposed to high glucose,” Biochemical and Biophysical Research Communications, vol. 366, no. 3, pp. 793–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. J. F. Passos, T. von Zglinicki, and G. Saretzki, “Mitochondrial dysfunction and cell senescence: cause or consequence?” Rejuvenation Research, vol. 9, no. 1, pp. 64–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. J. W. Shay, O. M. Pereira-Smith, and W. E. Wright, “A role for both RB and p53 in the regulation of human cellular senescence,” Experimental Cell Research, vol. 196, no. 1, pp. 33–39, 1991. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Chen, L. C. Trotman, D. Shaffer et al., “Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis,” Nature, vol. 436, no. 7051, pp. 725–730, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. K. S. Kim, K. W. Kang, Y. B. Seu, S. H. Baek, and J. R. Kim, “Interferon-γ induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells,” Mechanisms of Ageing and Development, vol. 130, no. 3, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. R. C. Allsopp, E. Chang, M. Kashefi-Aazam et al., “Telomere shortening is associated with cell division in vitro and in vivo,” Experimental Cell Research, vol. 220, no. 1, pp. 194–200, 1995. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Oikawa and S. Kawanishi, “Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening,” FEBS Letters, vol. 453, no. 3, pp. 365–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. W. C. Chou, H. Y. Chen, S. L. Yu, L. Cheng, P. C. Yang, and C. V. Dang, “Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation,” Blood, vol. 106, no. 1, pp. 304–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Barrera, S. Martinotti, V. Fazio et al., “Effect of 4-hydroxynonenal on c-myc expression,” Toxicologic Pathology, vol. 15, no. 2, pp. 238–240, 1987. View at Scopus
  81. V. M. Fazio, G. Barrera, S. Martinotti et al., “4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells,” Cancer Research, vol. 52, no. 18, pp. 4866–4871, 1992. View at Scopus
  82. G. Barrera, R. Muraca, S. Pizzimenti et al., “Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line,” Biochemical and Biophysical Research Communications, vol. 203, no. 1, pp. 553–561, 1994. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Barrera, S. Pizzimenti, A. Serra et al., “4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells,” Biochemical and Biophysical Research Communications, vol. 227, no. 2, pp. 589–593, 1996. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Pizzimenti, F. Briatore, S. Laurora et al., “4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines,” Free Radical Biology and Medicine, vol. 40, no. 9, pp. 1578–1591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Rinaldi, G. Barrera, A. Aquino et al., “4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation,” Biochemical and Biophysical Research Communications, vol. 272, no. 1, pp. 75–80, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Cerbone, C. Toaldo, S. Laurora et al., “4-Hydroxynonenal and PPARγ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells,” Free Radical Biology and Medicine, vol. 42, no. 11, pp. 1661–1670, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Barrera, S. Pizzimenti, R. Muraca et al., “Effect of 4-hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells,” Free Radical Biology and Medicine, vol. 20, no. 3, pp. 455–462, 1996. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Pizzimenti, G. Barrera, M. U. Dianzani, and S. Brüsselbach, “Inhibition of D1, D2, and A cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal,” Free Radical Biology and Medicine, vol. 26, no. 11-12, pp. 1578–1586, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Barrera, S. Pizzimenti, S. Laurora, E. Moroni, B. Giglioni, and M. U. Dianzani, “4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells,” Biochemical and Biophysical Research Communications, vol. 295, no. 2, pp. 267–275, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Barrera, S. Pizzimenti, and M. U. Dianzani, “4-Hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway,” Free Radical Biology and Medicine, vol. 37, no. 5, pp. 597–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Laurora, E. Tamagno, F. Briatore et al., “4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line,” Free Radical Biology and Medicine, vol. 38, no. 2, pp. 215–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Shiraishi and K. Naito, “Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on spermatogenesis and expression of p53 protein in male infertility,” Journal of Urology, vol. 178, no. 3, pp. 1012–1017, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Vizio, G. Poli, E. Chiarpotto, and F. Biasi, “4-Hydroxynonenal and TGF-β1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line,” BioFactors, vol. 24, no. 1–4, pp. 237–246, 2005. View at Scopus
  94. D. Zanetti, G. Poli, B. Vizio, B. Zingaro, E. Chiarpotto, and F. Biasi, “4-Hydroxynonenal and transforming growth factor-β1 expression in colon cancer,” Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 273–280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. C. D. Albright, E. Klem, A. A. Shah, and P. Gallagher, “Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation,” Experimental and Molecular Pathology, vol. 79, no. 2, pp. 118–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. S. B. Sunjic, A. Cipak, F. Rabuzin, R. Wildburger, and N. Zarkovic, “The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells,” BioFactors, vol. 24, no. 1–4, pp. 141–148, 2005. View at Scopus
  97. P. Pettazzoni, S. Pizzimenti, C. Toaldo et al., “Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells,” Free Radical Biology and Medicine, vol. 50, no. 2, pp. 313–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. R. A. Canuto, G. Muzio, M. Ferro et al., “Inhibition of class-3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in hepatoma cell lines,” Free Radical Biology and Medicine, vol. 26, no. 3-4, pp. 333–340, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. G. Muzio, A. Trombetta, G. Martinasso, R. A. Canuto, and M. Maggiora, “Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases,” Chemico-Biological Interactions, vol. 143-144, pp. 37–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Schneider, S. Giordano, B. R. Zelickson, et al., “Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress,” Free Radical Biology and Medicine, vol. 51, pp. 2007–2017, 2011.
  101. H. Kakishita and Y. Hattori, “Vascular smooth muscle cell activation and growth by 4-hydroxynonenal,” Life Sciences, vol. 69, no. 6, pp. 689–697, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Watanabe, R. Pakala, T. Katagiri, and C. R. Benedict, “Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation,” Atherosclerosis, vol. 155, no. 1, pp. 37–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. T. J. Lee, J. T. Lee, S. K. Moon, C. H. Kim, J. W. Park, and T. K. Kwon, “Age-related differential growth rate and respo61nse to 4-hydroxynonenal in mouse aortic smooth muscle cells,” International Journal of Molecular Medicine, vol. 17, pp. 29–35, 2006.
  104. C. Vindis, I. Escargueil-Blanc, K. Uchida, M. Elbaz, R. Salvayre, and A. Negre-Salvayre, “Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis,” Redox Report, vol. 12, no. 1-2, pp. 96–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Semlitsch, H. M. Tillian, N. Zarkovic et al., “Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes,” Anticancer Research, vol. 22, no. 3, pp. 1689–1697, 2002. View at Scopus
  106. D. C. Hassane, M. L. Guzman, C. Corbett et al., “Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data,” Blood, vol. 111, no. 12, pp. 5654–5662, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Behrend, G. Henderson, and R. M. Zwacka, “Reactive oxygen species in oncogenic transformation,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1441–1444, 2003. View at Scopus
  108. W. S. Wu, “The signaling mechanism of ROS in tumor progression,” Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 695–705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Pelicano, D. Carney, and P. Huang, “ROS stress in cancer cells and therapeutic implications,” Drug Resistance Updates, vol. 7, no. 2, pp. 97–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. P. T. Schumacker, “Reactive oxygen species in cancer cells: live by the sword, die by the sword,” Cancer Cell, vol. 10, no. 3, pp. 175–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. E. J. Wolvetang, K. L. Johnson, K. Krauer, S. J. Ralph, and A. W. Linnane, “.Mitochondrial respiratory chain inhibitors induce apoptosis,” FEBS Letters, vol. 339, pp. 40–44, 1994.
  112. J. S. Isenberg, K. L. Kolaja, S. A. Ayoubi, J. B. Watkins III, and J. E. Klaunig, “Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone,” Carcinogenesis, vol. 18, no. 8, pp. 1511–1519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  113. J. S. Armstrong, B. Hornung, P. Lecane, D. P. Jones, and S. J. Knox, “Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW,” Biochemical and Biophysical Research Communications, vol. 289, no. 5, pp. 973–978, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Tada-Oikawa, Y. Hiraku, M. Kawanishi, and S. Kawanishi, “Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis,” Life Sciences, vol. 73, no. 25, pp. 3277–3288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. W. G. Chung, C. L. Miranda, and C. S. Maier, “Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells,” Brain Research, vol. 1176, no. 1, pp. 133–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. T. Deng, H. C. Huang, and J. K. Lin, “Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling,” Molecular Carcinogenesis, vol. 49, no. 2, pp. 141–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. M. T. Hoyt, R. Palchaudhuri, and P. J. Hergenrother, “Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism,” Investigational New Drugs, vol. 29, no. 4, pp. 562–573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Sharma, A. Sharma, P. Chaudhary et al., “Role of lipid peroxidation in cellular responses to d, l -sulforaphane, a promising cancer chemopreventive agent,” Biochemistry, vol. 49, no. 14, pp. 3191–3202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. H. J. Wang, Y. Y. Jiang, X. F. Wei et al., “Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells,” Free Radical Research, vol. 44, no. 1, pp. 90–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. W. L. Wu, W. L. Chang, and C. F. Chen, “Cytotoxic activities of tanshinones against human carcinoma cell lines,” American Journal of Chinese Medicine, vol. 19, no. 3-4, pp. 207–216, 1991. View at Scopus
  121. W. Y. W. Lee, K. W. K. Liu, and J. H. K. Yeung, “Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells,” Cancer Letters, vol. 285, no. 1, pp. 46–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Hoelzl, J. Bichler, F. Ferk et al., “Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies,” Journal of Physiology and Pharmacology, vol. 56, no. 2, pp. 49–64, 2005. View at Scopus
  123. L. H. Russell Jr., E. Mazzio, R. B. Badisa, et al., “Autoxidation of gallic acid induces ROS-dependent death in human prostate cancer LNCaP cells,” Anticancer Research, vol. 32, pp. 1595–1602, 2012.
  124. T. Hongo, N. Miyano-Kurosaki, K. Kurosaki, A. Hata, S. Harigae, and A. Tomoda, “2-aminophenoxazine-3-one prevents pulmonary metastasis of mouse B16 melanoma cells in mice,” Journal of Pharmacological Sciences, vol. 114, no. 1, pp. 63–68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. C. L. Zheng, X. F. Che, S. I. Akiyama, K. Miyazawa, and A. Tomoda, “2-Aminophenoxazine-3-one induces cellular apoptosis by causing rapid intracellular acidification and generating reactive oxygen species in human lung adenocarcinoma cells,” International Journal of Oncology, vol. 36, no. 3, pp. 641–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. R. Feng, H. M. Ni, S. Y. Wang et al., “Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress,” Journal of Biological Chemistry, vol. 282, no. 18, pp. 13468–13476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Cvorovic, F. Tramer, M. Granzotto, L. Candussio, G. Decorti, and S. Passamonti, “Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells,” Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Koprowska and M. Czyz, “Molecular mechanisms of parthenolide's action: old drug with a new face,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 64, pp. 100–114, 2010. View at Scopus
  129. H. Nakshatri, S. E. Rice, and P. Bhat-Nakshatri, “Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase,” Oncogene, vol. 23, no. 44, pp. 7330–7344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. M. L. Guzman, R. M. Rossi, S. Neelakantan et al., “An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells,” Blood, vol. 110, no. 13, pp. 4427–4435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. C. Yang, C. K. Lii, A. H. Lin, et al., “Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress,” Free Radical Biology and Medicine, vol. 51, pp. 2073–2081, 2011.
  132. H. M. Prince and M. Dickinson, “Romidepsin for cutaneous T-cell lymphoma,” Clinical Cancer Research, vol. 18, no. 13, pp. 3509–3515, 2012.
  133. H. Mizutani, Y. Hiraku, S. Tada-Oikawa et al., “Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide,” Cancer Science, vol. 101, no. 10, pp. 2214–2219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. W. H. Chiu, S. J. Luo, C. L. Chen, et al., “Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells,” Biochemical Pharmacology, vol. 83, pp. 1159–1171, 2012.
  135. C. Casares, R. Ramírez-Camacho, A. Trinidad, A. Roldán, E. Jorge, and J. R. García-Berrocal, “Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models,” European Archives of Oto-Rhino-Laryngology. In press. View at Publisher · View at Google Scholar
  136. J. Fang, H. Nakamura, and A. K. Iyer, “Tumor-targeted induction of oxystress for cancer therapy,” Journal of Drug Targeting, vol. 15, no. 7-8, pp. 475–486, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. K. K. Kim, T. S. Lange, R. K. Singh, L. Brard, and R. G. Moore, “Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C,” BMC Cancer, vol. 12, p. 147, 2012.
  138. Y. W. Zhang, J. Shi, Y. J. Li, and L. Wei, “Cardiomyocyte death in doxorubicin-induced cardiotoxicity,” Archivum Immunologiae et Therapia Experimentalis, vol. 57, pp. 435–445, 2009.
  139. I. Müller, D. Niethammer, and G. Bruchelt, “Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review),” International Journal of Molecular Medicine, vol. 1, no. 2, pp. 491–494, 1998. View at Scopus
  140. Y. Pommier, “DNA topoisomerase I Inhibitors: chemistry, biology, and interfacial inhibition,” Chemical Reviews, vol. 109, no. 7, pp. 2894–2902, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. Y. Li, C. Rory Goodwin, Y. Sang, E. M. Rosen, J. Laterra, and S. Xia, “Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms,” Anti-Cancer Drugs, vol. 20, no. 9, pp. 770–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. X. J. Wu and X. Hua, “Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound,” Cancer Biology and Therapy, vol. 6, no. 5, pp. 646–647, 2007. View at Scopus
  143. X. Wei, W. Guo, S. Wu et al., “Oxidative stress in NSC-741909-induced apoptosis of cancer cells,” Journal of Translational Medicine, vol. 8, article 37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  144. B. Sung, B. Park, V. R. Yadav, and B. B. Aggarwal, “Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors,” Journal of Biological Chemistry, vol. 285, no. 15, pp. 11498–11507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. A. K. Maiti, “Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells,” International Journal of Cancer, vol. 130, no. 1, pp. 1–9, 2012.
  146. R. Kong, G. Jia, Z. X. Cheng, et al., “Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5,” PLoS ONE, vol. 7, Article ID e37222, 2012.
  147. M. A. Park, C. Mitchell, G. Zhang et al., “Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a CA2+-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway,” Cancer Research, vol. 70, no. 15, pp. 6313–6324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. M. Donadelli, C. Costanzo, S. Beghelli et al., “Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine,” Biochimica et Biophysica Acta, vol. 1773, no. 7, pp. 1095–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. H. Maeda, S. Hori, H. Ohizumi et al., “Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine,” Cell Death and Differentiation, vol. 11, no. 7, pp. 737–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. Z. Li, S. Yan, N. Attayan, S. Ramalingam, and C. J. Thiele, “Combination of an allosteric Akt inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma,” Clinical Cancer Research, vol. 18, no. 13, pp. 3603–3615, 2012.
  151. R. Cuperus, A. B. P. van Kuilenburg, R. Leen, J. Bras, H. N. Caron, and G. A. M. Tytgat, “Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids,” Free Radical Biology and Medicine, vol. 51, no. 6, pp. 1213–1220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. G. Chen, K. Wang, B. Y. Yang, B. Tang, J. X. Chen, and Z. C. Hua, “Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells,” International Journal of Oncology, vol. 40, pp. 139–147, 2012.
  153. P. Shen, T. Jiang, H. Lu, H. Han, and R. Luo, “Combination of Poly I: C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells,” Cell Biology International, vol. 35, pp. 803–810, 2011.
  154. H. Jiang, Y. Ma, X. Chen et al., “Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma,” Cancer Science, vol. 101, no. 4, pp. 975–983, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. J. J. Li, Q. Tang, Y. Li et al., “Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid,” Acta Pharmacologica Sinica, vol. 27, no. 8, pp. 1078–1084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Inoue, S. Muranaka, H. Fujita, T. Kanno, H. Tamai, and K. Utsumi, “Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome c, and caspase pathway,” Free Radical Biology and Medicine, vol. 37, no. 8, pp. 1290–1299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Rahmani, E. Reese, Y. Dai et al., “Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species,” Cancer Research, vol. 65, no. 6, pp. 2422–2432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. C. Yu, B. B. Friday, J. P. Lai et al., “Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation,” Clinical Cancer Research, vol. 13, no. 4, pp. 1140–1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. F. L. Khanim, R. E. Hayden, J. Birtwistle et al., “Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia,” PLoS ONE, vol. 4, no. 12, Article ID e8147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Jin, Z. Lu, K. Ding et al., “Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-κB pathway and generation of reactive oxygen species,” Cancer Research, vol. 70, no. 6, pp. 2516–2527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  161. S. H. Tonino, J. Van Laar, M. H. Van Oers, J. Y. Wang, E. Eldering, and A. P. Kater, “ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia,” Oncogene, vol. 30, no. 6, pp. 701–713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. S. Sturlan, M. Baumgartner, E. Roth, and T. Bachleitner-Hofmann, “Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells,” Blood, vol. 101, no. 12, pp. 4990–4997, 2003. View at Scopus
  163. M. Baumgartner, S. Sturlan, E. Roth, B. Wessner, and T. Bachleitner-Hofmann, “Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells,” International Journal of Cancer, vol. 112, no. 4, pp. 707–712, 2004. View at Publisher · View at Google Scholar · View at Scopus
  164. M. Wirtitsch, E. Roth, T. Bachleitner-Hofmann, B. Wessner, and S. Sturlan, “ω-3 and ω-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells,” Oncology Research, vol. 18, no. 2-3, pp. 83–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. F. M. Santandreu, A. Valle, J. Oliver, and P. Roca, “Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells,” Cellular Physiology and Biochemistry, vol. 28, pp. 219–228, 2011.
  166. F. Cai, Y. M. Dupertuis, and C. Pichard, “Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 15, pp. 99–106, 2012.
  167. P. Pettazzoni, S. Pizzimenti, C. Toaldo et al., “Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells,” Free Radical Biology and Medicine, vol. 50, no. 2, pp. 313–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  168. S. Pizzimenti, S. Laurora, F. Briatore, C. Ferretti, M. U. Dianzani, and G. Barrera, “Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation,” Free Radical Biology and Medicine, vol. 32, no. 3, pp. 233–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  169. B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg, “Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?” Journal of the National Cancer Institute, vol. 100, no. 11, pp. 773–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Borek, “Dietary antioxidants and human cancer,” Integrative Cancer Therapies, vol. 3, no. 4, pp. 333–341, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. B. Halliwell and J. M. C. Gutteridge, Free Radical Biology and Medicine, Oxford Calendron Press, 1989.
  172. B. N. Pandey and K. P. Mishra, “In-vitro studies on radiation induced membrane oxidative damage in apoptotic death thymocytes,” International Journal of Low Radiation, vol. 1, pp. 113–119, 2003.
  173. V. Bauer and F. Bauer, “Reactive oxygen species mediators of tissue protection and injury,” General Physiology and Biophysics, vol. 18, pp. 7–14, 1999. View at Scopus
  174. G. M. Ross, “Induction of cell death by radiotherapy,” Endocrine-Related Cancer, vol. 6, no. 1, pp. 41–44, 1999. View at Publisher · View at Google Scholar · View at Scopus
  175. V. Cardile, M. Bellia, L. Lombardo, C. Scifo, and M. Renis, “Distinct response to ionizing radiation of human prostate cell lines,” Oncology Reports, vol. 14, no. 4, pp. 981–985, 2005. View at Scopus
  176. K. S. Kumar, M. Raghavan, K. Hieber et al., “Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant γ-tocotrienol,” Life Sciences, vol. 78, no. 18, pp. 2099–2104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  177. K. D. Kikawa, J. S. Herrick, R. E. Tateo, M. Mouradian, J. S. Tay, and R. S. Pardini, “Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid,” Nutrition and Cancer, vol. 62, no. 8, pp. 1017–1024, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. K. Dittmann, C. Mayer, R. Kehlbach, M. C. Rothmund, and H. Peter Rodemann, “Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport,” Radiotherapy and Oncology, vol. 92, no. 3, pp. 379–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. K. Dittmann, C. Mayer, B. Fehrenbacher et al., “Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase,” Journal of Biological Chemistry, vol. 280, no. 35, pp. 31182–31189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  180. S. Girdhani, S. M. Bhosle, S. A. Thulsidas, A. Kumar, and K. P. Mishra, “Potential of radiosensitizing agents in cancer chemo-radiotherapy,” Journal of Cancer Research and Therapeutics, vol. 1, no. 3, pp. 129–131, 2005. View at Scopus
  181. G. Benais-Pont, Y. M. Dupertuis, M. P. Kossovsky et al., “ω-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells,” Nutrition, vol. 22, no. 9, pp. 931–939, 2006. View at Publisher · View at Google Scholar · View at Scopus
  182. B. Ramanathan, K. Y. Jan, C. H. Chen, T. C. Hour, H. J. Yu, and Y. S. Pu, “Resistance to paclitaxel is proportional to cellular total antioxidant capacity,” Cancer Research, vol. 65, no. 18, pp. 8455–8460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. J. Choi, R. M. Liu, and H. J. Forman, “Adaptation to oxidative stress: quinone-mediated protection of signaling in rat lung epithelial L2 cells,” Biochemical Pharmacology, vol. 53, no. 7, pp. 987–993, 1997. View at Publisher · View at Google Scholar · View at Scopus
  184. G. J. Kim, K. Chandrasekaran, and W. F. Morgan, “Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review,” Mutagenesis, vol. 21, no. 6, pp. 361–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  185. M. A. Ogasawara and H. Zhang, “Redox regulation and Its emerging roles in stem cells and stem-like cancer cells,” Antioxidants and Redox Signaling, vol. 11, no. 5, pp. 1107–1122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. M. B. Irmak, G. Ince, M. Ozturk, and R. Cetin-Atalay, “Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism?” Cancer Research, vol. 63, no. 20, pp. 6707–6715, 2003. View at Scopus
  187. A. K. Maiti, “Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells,” Pharmacogenomics Journal, vol. 10, no. 2, pp. 94–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  188. I. Boldogh, G. Roy, M. S. Lee et al., “Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress,” Toxicology, vol. 193, no. 1-2, pp. 137–152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  189. B. Ramanathan, K. Y. Jan, C. H. Chen, T. C. Hour, H. J. Yu, and Y. S. Pu, “Resistance to paclitaxel is proportional to cellular total antioxidant capacity,” Cancer Research, vol. 65, no. 18, pp. 8455–8460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  190. T. C. Hour, C. Y. Huang, C. C. Lin et al., “Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide,” Anti-Cancer Drugs, vol. 15, no. 8, pp. 779–785, 2004. View at Publisher · View at Google Scholar · View at Scopus
  191. K. E. de Visser and J. Jonkers, “Towards understanding the role of cancer-associated inflammation in chemoresistance,” Current Pharmaceutical Design, vol. 15, no. 16, pp. 1844–1853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  192. P. Borst, J. Jonkers, and S. Rottenberg, “What makes tumors multidrug resistant?” Cell Cycle, vol. 6, no. 22, pp. 2782–2787, 2007. View at Scopus
  193. C. A. Schmitt, J. S. Fridman, M. Yang et al., “A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy,” Cell, vol. 109, no. 3, pp. 335–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. G. Szakács, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman, “Targeting multidrug resistance in cancer,” Nature Reviews Drug Discovery, vol. 5, no. 3, pp. 219–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  195. N. Voorzanger-Rousselot, L. Alberti, and J. Y. Blay, “CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways,” BMC Cancer, vol. 6, article 75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  196. V. Bottero, V. Busuttil, A. Loubat et al., “Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells,” Cancer Research, vol. 61, no. 21, pp. 7785–7791, 2001. View at Scopus
  197. K. C. Das and C. W. White, “Activation of NF-κB by antineoplastic agents. Role of protein kinase C,” Journal of Biological Chemistry, vol. 272, no. 23, pp. 14914–14920, 1997. View at Publisher · View at Google Scholar · View at Scopus
  198. B. Piret and J. Piette, “Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells,” Nucleic Acids Research, vol. 24, no. 21, pp. 4242–4248, 1996. View at Publisher · View at Google Scholar · View at Scopus
  199. F. R. Greten, L. Eckmann, T. F. Greten et al., “IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer,” Cell, vol. 118, no. 3, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  200. J. Dutta, Y. Fan, N. Gupta, G. Fan, and C. Gélinas, “Current insights into the regulation of programmed cell death by NF-κB,” Oncogene, vol. 25, no. 51, pp. 6800–6816, 2006. View at Publisher · View at Google Scholar · View at Scopus
  201. W. Wang, J. Cassidy, V. O'Brien, K. M. Ryan, and E. Collie-Duguid, “Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells,” Cancer Research, vol. 64, no. 22, pp. 8167–8176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  202. X. Guo, B. Xu, S. Pandey et al., “Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines,” Cancer Letters, vol. 290, no. 1, pp. 104–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  203. S. K. Niture and A. K. Jaiswal, “Nrf2 up-regulates anti-apoptotic protein Bcl-2 and prevents cellular apoptosis,” The Journal of Biological Chemistry, vol. 287, pp. 9873–9886, 2012.
  204. T. C. Hour, C. Y. Huang, C. C. Lin et al., “Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide,” Anti-Cancer Drugs, vol. 15, no. 8, pp. 779–785, 2004. View at Publisher · View at Google Scholar · View at Scopus
  205. M. Polimeni, C. Voena, J. Kopecka et al., “Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity,” Biochemical Journal, vol. 439, pp. 141–149, 2011.
  206. H. R. Lee, J. M. Cho, D. H. Shin et al., “Adaptive response to GSH depletion and resistance to L-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation,” Molecular and Cellular Biochemistry, vol. 318, no. 1-2, pp. 23–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  207. J. W. Kaspar, S. K. Niture, and A. K. Jaiswal, “Nrf2:INrf2 (Keap1) signaling in oxidative stress,” Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1304–1309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  208. T. H. Rushmore and C. B. Pickett, “Glutathione S-transferases, structure, regulation, and therapeutic implications,” Journal of Biological Chemistry, vol. 268, no. 16, pp. 11475–11478, 1993. View at Scopus
  209. A. Sau, F. Pellizzari Tregno, F. Valentino, G. Federici, and A. M. Caccuri, “Glutathione transferases and development of new principles to overcome drug resistance,” Archives of Biochemistry and Biophysics, vol. 500, no. 2, pp. 116–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. N. Knoll, C. Ruhe, S. Veeriah et al., “Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate,” Toxicological Sciences, vol. 86, no. 1, pp. 27–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  211. A. Lau, N. F. Villeneuve, Z. Sun, P. K. Wong, and D. D. Zhang, “Dual roles of Nrf2 in cancer,” Pharmacological Research, vol. 58, no. 5-6, pp. 262–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. J. M. Cho, S. Manandhar, H. R. Lee, H. M. Park, and M. K. Kwak, “Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance,” Cancer Letters, vol. 260, no. 1-2, pp. 96–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  213. X. J. Wang, Z. Sun, N. F. Villeneuve et al., “Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2,” Carcinogenesis, vol. 29, no. 6, pp. 1235–1243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  214. A. Singh, V. Misra, R. K. Thimmulappa et al., “Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer,” PLoS Medicine, vol. 3, no. 10, article e420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  215. P. Pettazzoni, E. Ciamporcero, C. Medana, et al., “Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells,” Free Radical Biology and Medicine, vol. 51, pp. 1610–1618, 2011.
  216. J. T. McDonald, K. Kim, A. J. Norris et al., “Ionizing radiation activates the Nrf2 antioxidant response,” Cancer Research, vol. 70, no. 21, pp. 8886–8895, 2010. View at Publisher · View at Google Scholar · View at Scopus
  217. A. Singh, M. Bodas, N. Wakabayashi, F. Bunz, and S. Biswal, “Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance,” Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1627–1637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  218. S. Lee, M. J. Lim, M. H. Kim et al., “An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses,” Free Radical Biology and Medicine, vol. 53, no. 4, pp. 807–816, 2012.
  219. I. B. Holland and M. A. Blight, “ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans,” Journal of Molecular Biology, vol. 293, no. 2, pp. 381–399, 1999. View at Publisher · View at Google Scholar · View at Scopus
  220. C. M. Mahaffey, H. Zhang, A. Rinna, W. Holland, P. C. Mack, and H. J. Forman, “Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma,” Free Radical Biology and Medicine, vol. 46, no. 12, pp. 1650–1657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  221. C. Y. Zhang, Y. X. Feng, Y. Yu et al., “The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism superarray,” Basic and Clinical Pharmacology and Toxicology, vol. 99, no. 2, pp. 141–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  222. R. Vatsyayan, P. Chaudhary, P. C. R. Lelsani et al., “Role of RLIP76 in doxorubicin resistance in lung cancer (review),” International Journal of Oncology, vol. 34, no. 6, pp. 1505–1511, 2009. View at Publisher · View at Google Scholar · View at Scopus
  223. Y. C. Awasthi, R. Sharma, S. Yadav, S. Dwivedi, A. Sharma, and S. Awasthi, “The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance,” Current Drug Metabolism, vol. 8, no. 4, pp. 315–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  224. K. J. Drake, J. Singhal, S. Yadav et al., “RALBP1/RLIP76 mediates multidrug resistance,” International Journal of Oncology, vol. 30, no. 1, pp. 139–144, 2007. View at Scopus
  225. R. Sharma, A. Sharma, Y. Yang et al., “Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4-hydroxynonenal,” Acta Biochimica Polonica, vol. 49, no. 3, pp. 693–701, 2002. View at Scopus
  226. J. Singhal, S. S. Singhal, S. Yadav et al., “RLIP76 in defense of radiation poisoning,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 2, pp. 553–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  227. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  228. C. I. Kobayashi and T. Suda, “Regulation of reactive oxygen species in stem cells and cancer stem cells,” Journal of Cellular Physiology, vol. 227, pp. 421–430, 2012.
  229. T. M. Phillips, W. H. McBride, and F. Pajonk, “The response of CD24(-/low)/CD44þ breast cancer-initiating cells to radiation,” Journal of the National Cancer Institute, vol. 98, no. 24, pp. 1777–1785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  230. T. Ishimoto, O. Nagano, T. Yae et al., “CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc- and thereby promotes tumor growth,” Cancer Cell, vol. 19, no. 3, pp. 387–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  231. M. Diehn, R. W. Cho, N. A. Lobo et al., “Association of reactive oxygen species levels and radioresistance in cancer stem cells,” Nature, vol. 458, no. 7239, pp. 780–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  232. A. Cipak, L. Mrakovcic, M. Ciz et al., “Growth suppression of human breast carcinoma stem cells by lipid peroxidation product 4-hydroxy-2-nonenal and hydroxyl radical-modified collagen,” Acta Biochimica Polonica, vol. 57, no. 2, pp. 165–171, 2010. View at Scopus
  233. M. L. Guzman, R. M. Rossi, L. Karnischky et al., “The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells,” Blood, vol. 105, no. 11, pp. 4163–4169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  234. K. Ito, R. Bernardi, A. Morotti et al., “PML targeting eradicates quiescent leukaemia-initiating cells,” Nature, vol. 453, no. 7198, pp. 1072–1078, 2008. View at Publisher · View at Google Scholar · View at Scopus